Featured

Featured

The Value of Over the Top Data – PeerLogix (LOGX)

For those of you that haven’t noticed, cable companies have been spending a fortune just to keep their existing customers. Why? Well, the growing...

Epidiolex Set for FDA Approval, Cannabis M&A Heats Up

Earlier this month, an FDA Advisory Panel voted unanimously to recommend that the FDA formally approve first ever cannabis-based drug, Epidiolex. Manufactured by GW...

Vital Therapies, Inc. (Nasdaq: VTL): The Biotech Name Smart Money Owns

I was recently introduced to Vital Therapies, Inc. (Nasdaq: VTL) and the person who introduced me is a sharp investor and knows how to...

The 10 Year Treasury Rises & Equities Falter, Why?

By Ross Silver, CEO of SylvaCap Media Investopedia has an excellent article that discusses what happens in an environment where rates go up. It seems...

Two Macroeconomic Factors Impacting Small Caps

Key Takeaways This earnings season, ignore earnings growth and focus on revenue and gross margins If Dodd-Frank amendments pass, regional banks will not benefit...

Two Small Caps Leading the CRISPR Biotech Revolution

In the last few years, there has been a lot of media coverage and excitement about a new procedure to edit DNA called CRISPR-CAS9...

What’s Killing Small Cap IPOs?

The Wall Street Journalrecently published an article proclaiming that “Small IPOs Are Dying – That’s Good”. The Journal article noted that Venture Capital financing...

FDA Advisory Committee Unanimously Approves Cannabis Based Drug, Epidiolex: 4 Small Cap Companies that...

On April 19th, an advisory panel for the Food and Drug Administration (FDA) unanimously recommended that the FDA approve Epidiolex, a cannabis based treatment...

This Small Cap Could Benefit From $70 Oil

A recent confluence of world events has driven oil prices past the $70 mark.  Strong global demand in conjunction with depleted reserves, OPEC-led production...
video

Why We Like Small Cap Biotech

We discuss: Atossa Genetics (ATOS) Vital Therapies (VTL) Aerpio Pharmaceuticals (ARPO) Ross or his family owns: ARPO Greg or his family owns: None

Protectionism and Tax Cuts Favor Small Cap

Key Takeaways: Protectionism and tax cuts could benefit small cap companies more than than multi-national large caps Russell 2000 Index could be poised to...

Enter your email below to receive free content